Healthcare -
Biotechnology - NASDAQ - US
$ 3.6301
4.61 %
$ 2.65 B
Market Cap
-4.03
P/E
IBRX - STOCK-BASED COMPENSATION
Stock-based Compensation IBRX - ImmunityBio, Inc.
49.2 M
LAST VALUE
-7.28%
2 YEAR CAGR
88.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR